Alamar Biosciences Sees FY2026 Sales $116.000M-$120.000M vs $113.259M Est
Alamar Biosciences (NASDAQ:ALMR) sees FY2026 sales of $116.000 million-$120.000 million vs $113.259 million analyst estimate.
Alamar expects to make slightly more money next year than experts predicted—between $116 million and $120 million instead of $113 million. When a company's own forecast beats what experts guessed, it can show the company feels confident about its business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.